The life science IP commercialisation company Aitua Limited (“Aitua”) is pleased to announce that it has invested £100,000 into Innova BioSciences Limited (“Innova"). Innova will use the proceeds to develop its product pipeline, which currently includes the Lightning-Link™ family of conjugation products which massively simplify the production of immunodiagnostics reagents.
